Urinary matrix metalloproteinase-8 and -9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy?
Authors:
- Nynke J. van der ZijlNZNynke J. van der Zijl
- Roeland HanemaaijerRHRoeland Hanemaaijer
- Maarten E. TushuizenMTMaarten E. Tushuizen
- Roger K. SchindhelmRSRoger K. Schindhelm
- Jeannette BoeropJBJeannette Boerop
- Cees RustemeijerCRCees Rustemeijer
- Henk J. BiloHBHenk J. Bilo
- Jan H. VerheijenJVJan H. Verheijen
- Michaela DiamantMDMichaela Diamant
- 1 May 2010
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 43 (7-8) , 635-639
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Matrix Metalloproteinase-2 Dysregulation in Type 1 DiabetesDiabetes Care, 2007
- Determination of urinary enzymes as a marker of early renal damage in diabetic patientsJournal of Clinical Laboratory Analysis, 2007
- Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic NephropathyDiabetes Care, 2006
- High Ambient Glucose Levels Modulates the Production of MMP-9 and a5(IV) Collagen by Cultured PodocytesCellular Physiology and Biochemistry, 2006
- Estimation of Glomerular Filtration Rate in Diabetic SubjectsDiabetes Care, 2005
- Role of lipid control in diabetic nephropathyKidney International, 2005
- Levels of urinary matrix metalloproteinase‐9 (MMP‐9) and renal injuries in patients with type 2 diabetic nephropathyJournal of Clinical Laboratory Analysis, 2004
- Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathyKidney International, 2001
- Does Microalbuminuria Predict Diabetic Nephropathy?Diabetes Care, 2001
- LettersDiabetic Medicine, 2001